B3i, a consortium startup working to use blockchain tech in the insurance industry, has launched its first product on R3's Corda platform.
Revealed Wednesday, the release of B3i's v1.0 of its Property Catastrophe Excess of Loss Reinsurance product comes a year after the firm's announcement that it would use Corda to build its future products.
The new Cat XoL product is aimed to bring greater speed and lower cost to the market, allowing insurers, brokers and reinsurers to "interact, negotiate and place risk more securely and efficiently."
The firm said:
The product removes the need for some of the manual and time-consuming tasks from the process of renewing an insurance treaty. It also ensures only relevant parties are given real-time access to the contract terms and conditions, offerings and signatures, removing the "contract uncertainty" that afflicts the current manual process, explained the firm.
Operational risk is also said to be reduced thanks to the elimination of manual errors such as double entries of data.
B3i said it has "worked with the market" to develop the product.
Sylvain De Crom, B3i's chief product officer, said:
The firm's CEO, John Carolin – who was appointed in July – added: “This is a pivotal moment for B3i."
In February, the startup quietly raised about $16 million, bringing its total funding to over $22 million, according to corporate registry filings in Switzerland.
John Carolin image courtesy of B3i
The leader in news and information on cryptocurrency, digital assets and the future of money, CoinDesk is a media outlet that strives for the highest journalistic standards and abides by a strict set of editorial policies. CoinDesk is an independent operating subsidiary of Digital Currency Group, which invests in cryptocurrencies and blockchain startups. As part of their compensation, certain CoinDesk employees, including editorial employees, may receive exposure to DCG equity in the form of stock appreciation rights, which vest over a multi-year period. CoinDesk journalists are not allowed to purchase stock outright in DCG.